KAZIA THERAPEUTICS LTD Logo

KAZIA THERAPEUTICS LTD

Oncology-focused biotech developing targeted therapies for cancers with high unmet needs.

KZIA | US

Overview

Corporate Details

ISIN(s):
N/A
LEI:
Country:
United States of America
Address:
THREE INTERNATIONAL TOWERS LEVEL 24,, 2000 SYDNEY NSW

Description

Kazia Therapeutics Ltd. is an oncology-focused biotechnology company engaged in the development of innovative drugs for cancer. The company's lead program is paxalisib, a small molecule inhibitor of the PI3K/AKT/mTOR pathway designed to cross the blood-brain barrier, which is being investigated for various forms of brain cancer. Its development pipeline also includes EVT801, a selective VEGFR3 inhibitor being studied for its potential to block the growth of blood and lymphatic vessels that support tumor growth. The company focuses on addressing cancers with high unmet medical needs through its portfolio of targeted therapies.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-12-23 18:27
424B3
English 208.7 KB
2025-12-23 18:27
424B3
English 173.3 KB
2025-12-23 17:06
424B3
English 153.5 KB
2025-12-23 17:06
424B3
English 177.3 KB
2025-12-23 01:15 English 5.3 KB
2025-12-23 01:15 English 5.3 KB
2025-12-19 22:46
POS AM
English 203.6 KB
2025-12-19 22:46
POS AM
English 179.9 KB
2025-12-19 22:45
F-1/A
English 198.5 KB
2025-12-19 22:44
F-1
English 444.6 KB
2025-12-19 22:01
6-K
English 8.9 KB
2025-12-18 20:21 English 9.4 KB
2025-12-10 22:11
6-K
English 19.5 KB
2025-12-05 22:05
6-K
English 12.0 KB
2025-12-02 22:05
6-K
English 192.4 KB

Automate Your Workflow. Get a real-time feed of all KAZIA THERAPEUTICS LTD filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for KAZIA THERAPEUTICS LTD

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for KAZIA THERAPEUTICS LTD via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

IMMUNIC, INC. Logo
Develops oral small molecule therapies for chronic inflammatory and autoimmune diseases.
United States of America
IMUX
Immunovant, Inc. Logo
Clinical-stage immunology company developing anti-FcRn antibodies for autoimmune diseases.
United States of America
IMVT
IMMUPHARMA PLC Logo
Specialty biopharmaceutical company developing peptide-based therapeutics.
United Kingdom
IMM
IMMUTEP Ltd Logo
Biotechnology company developing LAG-3 immunotherapies for cancer and autoimmune diseases.
United States of America
IMMP
IMPACT BIOMEDICAL INC. Logo
Develops biopharmaceutical products and technologies to protect against pathogens.
United States of America
IBO
INBIOGEN CO.,Ltd Logo
A life sciences firm offering bioinformatics and data mining services to biotech firms.
South Korea
101140
Incannex Healthcare Inc. Logo
A clinical-stage biopharma firm developing cannabinoid and psychedelic-based therapies.
United States of America
IXHL
Indaptus Therapeutics, Inc. Logo
Develops bacterial-based immunotherapies for cancer and viral infections.
United States of America
INDP
InflaRx N.V. Logo
Clinical-stage biopharmaceutical firm developing C5a/C5aR pathway inhibitors.
United States of America
IFRX
Inhalation Sciences Sweden AB Logo
Develops lab instruments and provides research for preclinical inhaled therapies.
Sweden
ISAB

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.